Below a list of forthcoming submissions that have recently been added to the SMC's programme. Information in relation to the drug indication, the date SMC advice is due to be published, as well as the deadline date for a Patient Group Submission, can be obtained from the SMC website.

Recently Added Forthcoming Submissions:         

• Bevacizumab (Avastin)
• Darunavir ethanolate with cobicistat (Rezolsta)
• Darunavir ethanolate (Prezista)
• Enzalutamide (Xtandi)
• Levonorgesterel (Levosert)
• Linagliptin with metformin hydrochloride (Jentadueto)
• Lisdexamfetamine dimesylate (Elvanse)
• Riociguat (Adempas)
• Rivaroxaban (Xarelto)
• Sorafenib tosylate (Nexavar)
• Tedizolid phosphate (Sivextro)
• Vedolizumab (Entyvio)
• Vinflunine tartrate (Javlor)

For more details, go to: http://www.scottishmedicines.org.uk/SMC_Advice/Forthcoming_Submissions/Forthcoming_Submissions?iru=2ICSSBDQBC